Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free BIVIW Stock Alerts

BioVie (BIVIW) Competitors

BioVie logo
$0.30 +0.03 (+10.95%)
As of 05/15/2026 03:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

BIVIW vs. SXTPW, DRTSW, APLMW, CDIOW, and CELUW

Should you buy BioVie stock or one of its competitors? MarketBeat compares BioVie with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BioVie include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Cardio Diagnostics (CDIOW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does BioVie compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than BioVie. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 1 mentions for BioVie. BioVie's average media sentiment score of 1.87 beat 60 Degrees Pharmaceuticals' score of 0.44 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
BioVie Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats BioVie on 2 of the 3 factors compared between the two stocks.

How does BioVie compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

In the previous week, Alpha Tau Medical had 2 more articles in the media than BioVie. MarketBeat recorded 3 mentions for Alpha Tau Medical and 1 mentions for BioVie. BioVie's average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.19 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Neutral
BioVie Very Positive

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
BioVie N/A N/A N/A

Summary

Alpha Tau Medical and BioVie tied by winning 1 of the 2 factors compared between the two stocks.

How does BioVie compare to Apollomics?

BioVie (NASDAQ:BIVIW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

In the previous week, BioVie and BioVie both had 1 articles in the media. Apollomics' average media sentiment score of 1.89 beat BioVie's score of 1.87 indicating that Apollomics is being referred to more favorably in the news media.

Company Overall Sentiment
BioVie Very Positive
Apollomics Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Apollomics beats BioVie on 2 of the 2 factors compared between the two stocks.

How does BioVie compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

In the previous week, Cardio Diagnostics had 1 more articles in the media than BioVie. MarketBeat recorded 2 mentions for Cardio Diagnostics and 1 mentions for BioVie. BioVie's average media sentiment score of 1.87 beat Cardio Diagnostics' score of 0.43 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
Cardio Diagnostics Neutral
BioVie Very Positive

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$14.83KN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

Cardio Diagnostics beats BioVie on 2 of the 3 factors compared between the two stocks.

How does BioVie compare to Celularity?

BioVie (NASDAQ:BIVIW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

In the previous week, Celularity had 2 more articles in the media than BioVie. MarketBeat recorded 3 mentions for Celularity and 1 mentions for BioVie. BioVie's average media sentiment score of 1.87 beat Celularity's score of 0.05 indicating that BioVie is being referred to more favorably in the media.

Company Overall Sentiment
BioVie Very Positive
Celularity Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Celularity N/A N/A N/A

Summary

Celularity beats BioVie on 2 of the 3 factors compared between the two stocks.

Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIVIW vs. The Competition

Export
MetricBioVieBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$466.99M$6.43B$12.48B
Dividend YieldN/A3.86%2.80%5.25%
P/E RatioN/A3.8720.3825.24
Price / SalesN/A7,766.11566.1982.25
Price / CashN/A13.1343.0456.04
Price / BookN/A84.219.876.90
Net IncomeN/A-$96.07M$3.57B$334.66M
7 Day Performance5.61%0.98%0.31%0.13%
1 Month Performance7.50%0.43%-1.27%1.11%
1 Year PerformanceN/A69.18%33.54%30.62%

BioVie Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIVIW
BioVie
N/A$0.30
+10.9%		N/AN/A$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
+0.2%		N/A-32.7%$0.00$1.01MN/A2
DRTSW
Alpha Tau Medical
N/A$1.31
+33.6%		N/A+847.1%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
-5.7%		N/A+27.0%$0.00$8.50MN/A59
CDIOW
Cardio Diagnostics
N/A$0.01
+0.7%		N/A-16.2%$0.00$14.83KN/A7

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BIVIW) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel